1. Tumour microenvironment (TME) characterization identified prognosis and immunotherapy response in muscle-invasive bladder cancer (MIBC)

   • Rui Cao
   • Lushun Yuan
   • Ye Tian

   Original Article 02 July 2020 Pages: 1 - 18

   

2. Serum levels of the IL-6 family of cytokines predict prognosis in renal cell carcinoma (RCC)

   • Gigja Gudbrandsdottir
   • Helene H. Aarstad
   • Christian Beisland

   Original Article Open access 03 July 2020 Pages: 19 - 30

   

3. Potent anti-myeloma efficacy of dendritic cell therapy in combination with pomalidomide and programmed death-ligand 1 blockade in a preclinical model of multiple myeloma

   • Tan-Huy Chu
   • Manh-Cuong Vo
   • Je-Jung Lee

   Original Article 04 July 2020 Pages: 31 - 45

   

4. Differential immune microenvironmental features of microsatellite-unstable colorectal cancers according to Fusobacterium nucleatum status

   • Ji Ae Lee
   • Seung-Yeon Yoo
   • Jung Ho Kim

   Original Article 04 July 2020 Pages: 47 - 59

   

5. Romidepsin (FK228) regulates the expression of the immune checkpoint ligand PD-L1 and suppresses cellular immune functions in colon cancer

   • Yehui Shi
   • Ying Fu
   • Hui Li

   Original Article Open access 06 July 2020 Pages: 61 - 73

   

6. CD66b⁺ monocytes represent a proinflammatory myeloid subpopulation in cancer

   • Utku Horzum
   • Digdem Yoyen-Ermis
   • Gunes Esendagli

   Original Article 06 July 2020 Pages: 75 - 87

   

7. Body mass index and immune-related adverse events in patients on immune checkpoint inhibitor therapies: a systematic review and meta-analysis

   • Yuli Guzman-Prado
   • Jennifer Ben Shimol
   • Ondrej Samson

   Original Article 09 July 2020 Pages: 89 - 100

   

8. Characteristics of patients with EGFR-mutant non-small-cell lung cancer who benefited from immune checkpoint inhibitors

   • Eiki Ichihara
   • Daijiro Harada
   • Katsuyuki Kiura

   Original Article 10 July 2020 Pages: 101 - 106

   

9. Selective BET-bromodomain inhibition by JQ1 suppresses dendritic cell maturation and antigen-specific T-cell responses

   • Niklas Remke
   • Savita Bisht
   • Peter Brossart

   Original Article 10 July 2020 Pages: 107 - 121

   

10. Interleukin-38 promotes tumor growth through regulation of CD8⁺ tumor-infiltrating lymphocytes in lung cancer tumor microenvironment

    • Fumihiko Kinoshita
    • Tetsuzo Tagawa
    • Masaki Mori

    Original Article 11 July 2020 Pages: 123 - 135

    

11. ZFHX3 mutation as a protective biomarker for immune checkpoint blockade in non-small cell lung cancer

    • Jiexia Zhang
    • Ningning Zhou
    • Jian Zhang

    Original Article 11 July 2020 Pages: 137 - 151

    

12. TGF-βR inhibitor SB431542 restores immune suppression induced by regulatory B–T cell axis and decreases tumour burden in murine fibrosarcoma

    • Kavitha Premkumar
    • Bhavani S. Shankar

    Original Article 13 July 2020 Pages: 153 - 168

    

13. NF2 mutation status and tumor mutational burden correlate with immune cell infiltration in meningiomas

    • John W. Rutland
    • Corey M. Gill
    • Mary Fowkes

    Original Article 13 July 2020 Pages: 169 - 176

    

14. Mechanism of action of a T cell-dependent bispecific antibody as a breakthrough immunotherapy against refractory colorectal cancer with an oncogenic mutation

    • Daisuke Kamakura
    • Ryutaro Asano
    • Masahiro Yasunaga

    Original Article Open access 14 July 2020 Pages: 177 - 188

    

15. Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels tumour heterogeneity plus M2-like tumour-associated macrophage infiltration and aggressiveness in TNBC

    • Xuanwen Bao
    • Run Shi
    • Weijia Fang

    Original Article 17 July 2020 Pages: 189 - 202

    

16. Leukotriene receptor antagonists enhance HCC treatment efficacy by inhibiting ADAMs and suppressing MICA shedding

    • Jun Arai
    • Kaku Goto
    • Hitoshi Yoshida

    Original Article Open access 18 July 2020 Pages: 203 - 213

    

17. Human leukocyte antigen expression in paired primary lung tumors and brain metastases in non-small cell lung cancer

    • Jarrett J. Failing
    • Marie Christine Aubry
    • Aaron S. Mansfield

    Original Article 21 July 2020 Pages: 215 - 219

    

18. Patterns of progression in patients treated for immuno-oncology antibodies combination

    • Alice Bernard-Tessier
    • Capucine Baldini
    • Samy Ammari

    Original Article 22 July 2020 Pages: 221 - 232

    

19. Impact of histamine H4 receptor deficiency on the modulation of T cells in a murine breast cancer model

    • Melisa B. Nicoud
    • Mónica A. Táquez Delgado
    • Vanina A. Medina

    Original Article 22 July 2020 Pages: 233 - 244

    

20. Prediction of non-muscle-invasive bladder cancer recurrence during intravesical BCG immunotherapy by use of peripheral blood eosinophil count and percentage: a preliminary report

    • Mustafa Zafer Temiz
    • Aykut Colakerol
    • Ahmet Yaser Muslumanoglu

    Original Article 22 July 2020 Pages: 245 - 252

    

21. Identification of two distinct populations of WT1-specific cytotoxic T lymphocytes in co-vaccination of WT1 killer and helper peptides

    • Fumihiro Fujiki
    • Akihiro Tsuboi
    • Haruo Sugiyama

    Original Article 22 July 2020 Pages: 253 - 263